Thanks, Martin, and good morning, everyone. I will now provide you with some additional details on the first quarter 2024 financial results. I will then discuss the drivers of our improved outlook for the 2024 full fiscal year. For the first quarter of 2024, net sales increased $2 million or 2% year-over-year to $112 million, driven by Vita Coco Coconut Water growth of 1% and net sales and private label growth of 6%. On a segment basis, within the Americas, Vita Coco Coconut Water increased net sales by 1% to $70 million, while private label decreased 3% to $24 million as we have started to see the impact of the transition of private label oil. Vita Coco Coconut Water saw a negative 3% volume decline, offset by 4% net price/mix benefit, while private label increased 4% in volume, which was partially offset by price mix changes driving year-to-date net sales decline of 3%. Our American Vita Coco coconut water scan trends remain very healthy, and we believe our shipments in the quarter reflect the absence of some promotional activity in untracked channels relative to 2023 same time period, a decrease in DSD inventory levels during the quarter and timing of shipments to key retailers. For the first quarter 2024, our International segment net sales were up 20%, with Vita Coco coconut water growth of 1%, where strong growth in Europe was partially offset by volume softness in Asia. Private label revenue grew 93%, which continues to benefit from new business gains at large European retailers. On a quarterly basis, consolidated gross profit was $47 million, up $14 million versus the prior year period. On a percentage basis, gross margins were very strong 42% in the quarter, an improvement of approximately 1,200 basis points over the 31% reported in Q1 2023. These increases resulted from branded pricing, mix effects within private label products and decreased global transportation costs. Moving on to operating expenses. First quarter 2024 SG&A costs increased 5% to $28 million, primarily reflecting increased people expenses. Net income attributable to shareholders for the first quarter 2024 was $14 million or $0.24 per diluted share compared to $7 million or $0.12 per diluted share for the prior year. Net income for the quarter benefited from increased gross profit, partially offset by increased SG&A costs, a lower year-on-year impact from unrealized FX derivatives and higher year-on-year tax expense. Our effective tax rate for the first quarter 2024 was 21%, which was flat to the prior year. First quarter 2024 adjusted EBITDA, our non-GAAP measure, which is defined and reconciled in our press release, was $21 million or 19% of net sales, up from $9 million or 8.2% of net sales in 2023. The increase was primarily due to the gross profit improvements previously discussed. Turning to our balance sheet and cash flow. As of March 31, 2024, we had total cash on hand of $123 million and no debt under our revolving credit facility compared to $133 million of cash and no debt as of December 31, 2023. The decrease in the cash position was due to the net increase of working capital of $20 million and the purchase of treasury shares of $10 million, partially offset by strong net income. Working capital was driven by an $8 million increase in accounts receivable as well as a $4 million decrease in accounts payable and accrued expenses, both are due to the seasonality of customer and vendor payments. Inventory increased by $6 million as the inventory delays, Martin discussed earlier have resulted in higher inventory in transit to our markets. Based on our year-to-date performance and our confidence in the health of the category and our Vita Coco brand, we are raising our full year guidance. We now expect net sales between $500 million and $510 million, with expected gross margin for the full year of 37% to 39%, delivering adjusted EBITDA of $76 million to $82 million. The guidance reflects our current best assumptions of the marketplace and our global supply chain costs. While we are confident in the underlying strength of our business, we are providing a wider range on EBITDA to reflect some uncertainty on the transportation cost side. We will actively manage our promotional activity to balance our product supply and our pricing, which will allow us to deliver the gross margin guidance while absorbing higher ocean freight costs, which will begin impacting our P&L in Q2. We expect disciplined SG&A spending throughout 2024 with full year SG&A flat to slightly increasing year-on-year. We may adjust our SG&A spending if we see improvements in Ocean Freight quicker than expected or if we see productive investment opportunities to strengthen the business for the long term. We anticipate our cash balance will remain healthy through the year, allowing us to fund any potential M&A opportunities that emerge, support further share buyback activity and continue to invest in our business for long-term growth. And with that, I'd like to turn the call back to Martin for his closing remarks.